Risedronate Sodium Tablets IP 30mg Technical Specification:
| Product Name: | Risedronate Sodium Tablets IP 30mg |
| Brand Name: | Generic |
| Strength: | (5mg), (30mg), (35mg), (150mg) |
| Dosage Form: | Tablets (Film-coated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antiosteoporotic |
| Indication: | Risedronate is for use when you have a high risk of bone fracture due to osteoporosis. |
| Storage: | Protect from light and Moisture, Store at a temperature not exceeding 30°C. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Risedronate Sodium Tablets IP 5mg
- Risedronate Sodium Tablets IP 30mg
- Risedronate Sodium Tablets IP 35mg
- Risedronate Sodium Tablets IP 150mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Risedronate Sodium Tablets IP 5mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………5mg
Excipients……………………………………………….q.s.
Colour: Caramel
- Risedronate Sodium Tablets IP 30mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………30mg
Excipients……………………………………………….q.s.
Colour: Sunset Yellow FCF
- Risedronate Sodium Tablets IP 35mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………35mg
Excipients……………………………………………….q.s.
Colour: Titanium dioxide IP
- Risedronate Sodium Tablets IP 150mg
Each film-coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………150mg
Excipients……………………………………………….q.s.
Colour: Tartrazine yellow
THERAPEUTIC INDICATIONS:
Risedronate is used by adults to treat a disease that weakens bones (Paget’s disease). This medication helps to reduce bone pain and may prevent long-term complications from this disease. Risedronate works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). It belongs to a class of medications called bisphosphonates.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
Warning: To be sold by retail on the prescription of Endocrinologist/Rheumatologist/gynaecologist/Orthopedics surgeon only.
STORAGE & DOSAGE:
Storage: Protect from light and Moisture, Store at a temperature not exceeding 30°C.
Dosage: One tablet same day every week.
GENERIC NAME OF THE MEDICINAL PRODUCT:
A) Risedronate Sodium Tablets IP 5mg
B) Risedronate Sodium Tablets IP 30mg
C) Risedronate Sodium Tablets IP 35mg
D) Risedronate Sodium Tablets IP 150mg
B) Risedronate Sodium Tablets IP 30mg
C) Risedronate Sodium Tablets IP 35mg
D) Risedronate Sodium Tablets IP 150mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Risedronate Sodium Tablets IP 5mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………5mg
Excipients……………………………………………….q.s.
Colour: Caramel
B) Risedronate Sodium Tablets IP 30mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………30mg
Excipients……………………………………………….q.s.
Colour: Sunset Yellow FCF
C) Risedronate Sodium Tablets IP 35mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………35mg
Excipients……………………………………………….q.s.
Colour: Titanium dioxide
D) Risedronate Sodium Tablets IP 150mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………150mg
Excipients……………………………………………….q.s.
Colour: Tartrazine yellow
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………5mg
Excipients……………………………………………….q.s.
Colour: Caramel
B) Risedronate Sodium Tablets IP 30mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………30mg
Excipients……………………………………………….q.s.
Colour: Sunset Yellow FCF
C) Risedronate Sodium Tablets IP 35mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………35mg
Excipients……………………………………………….q.s.
Colour: Titanium dioxide
D) Risedronate Sodium Tablets IP 150mg
Each film coated tablet contains:
Risedronate Sodium Hemi-Pentahydrate IP
Equivalent to Risedronate Sodium…………150mg
Excipients……………………………………………….q.s.
Colour: Tartrazine yellow
THERAPEUTIC INDICATIONS:
Risedronate is used by adults to treat a disease that weakens bones (Paget's disease). This medication helps to reduce bone pain and may prevent long-term complications from this disease. Risedronate works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). It belongs to a class of medications called bisphosphonates.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of Endocrinologist/Rheumatologist/Gynecologists/Orthopedics surgeon only.
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of Endocrinologist/Rheumatologist/Gynecologists/Orthopedics surgeon only.
STORAGE & DOSAGE:
Storage: Protect from light and Moisture, Store at a temperature not exceeding 30°C.
Dosage: One tablet same day every week.
Dosage: One tablet same day every week.










